Vietnam’s radiology AI market is estimated at US$10–20 million in 2025, with potential to reach US$35–65 million by 2030. Growing adoption of AI-assisted diagnostics, digital imaging and clinical workflow technologies is creating opportunities for software developers, imaging manufacturers and healthcare technology providers.
Vietnam’s diagnostic imaging market is forecast to grow from US$232.8 million in 2025 to US$353.3 million by 2034. Hospital modernisation, rising demand for early diagnosis and advances in AI-assisted imaging are creating opportunities across medical equipment, imaging software, connected diagnostics and specialist services.
Vietnam’s patient handling equipment market is estimated at US$60–90 million in 2025, with potential to reach US$90–135 million by 2030. Hospital expansion, an ageing population and greater emphasis on patient safety are creating opportunities across lifting systems, transfer equipment, hospital beds and advanced mobility solutions.
Vietnam’s topical drug delivery market is expanding as demand for non-invasive treatments, dermatology care and accessible healthcare grows. Valued at approximately US$1.24 billion in 2025, the market is forecast to reach US$1.88 billion by 2030, driven by rising skin disorders, healthcare investment and growing use of creams, gels, patches and other topical therapies.
Vietnam’s healthcare BPO market is expanding as digitalisation, electronic medical records and growing operational complexity drive demand for outsourced healthcare services. Valued at US$139.3 million in 2025, the market is forecast to reach US$252.1 million by 2034, creating opportunities across medical billing, claims processing, data management, analytics and patient support.
Vietnam’s home healthcare market is expanding as an ageing population, rising chronic disease and hospital capacity pressures increase demand for care outside traditional healthcare settings. Valued at US$1.86 billion in 2025, the market is forecast to reach US$4.11 billion by 2034, supported by telemedicine, remote monitoring, rehabilitation and growing demand for personalised care at home.
Vietnam’s AI-powered Remote Patient Monitoring market is emerging as connected devices, predictive analytics and digital healthcare technologies enable earlier intervention and more proactive management of chronic conditions.
Vietnam’s Clinical Decision Support market is gaining momentum as hospitals accelerate digital transformation and AI increasingly integrates patient data, medical knowledge and predictive analytics into clinical workflows.
Vietnam’s digital health market is expanding rapidly as telemedicine, AI, electronic health records and connected medical devices reshape healthcare delivery, with the market forecast to reach US$9.52 billion by 2034.
Vietnam’s cancer vaccine market is emerging as advances in immunotherapy, mRNA and personalised medicine create new opportunities across oncology, biopharmaceutical R&D and next-generation vaccine technologies.
Vietnam’s Remote Patient Monitoring market is expanding as connected healthcare, AI and digital technologies enable patients to receive more continuous care beyond traditional hospital settings.
Vietnam’s Active Wound Care market is evolving as diabetes, an ageing population and advances in regenerative medicine drive demand for technologies that support faster and more effective healing of complex and chronic wounds.
Vietnam’s digital biomarkers market is emerging as wearables, AI and remote monitoring reshape healthcare, creating new opportunities across chronic disease management, clinical research and personalised care.
Vietnam’s patient experience technology market is emerging as healthcare providers adopt digital tools to improve how patients access and interact with health services. Estimated at US$90–130 million in 2025, it could reach US$160–230 million by 2030. Growth in patient portals, digital booking, telehealth, mobile health, AI-powered engagement and personalised communication is creating new opportunities across Vietnam’s digital health ecosystem.
Vietnam’s Process Analytical Technology market is emerging as pharmaceutical and biotechnology manufacturers invest in automation, real-time monitoring and advanced quality control. Estimated at US$25–40 million in 2025, it could reach US$40–65 million by 2030. Growing adoption of spectroscopy, sensors, continuous manufacturing, Quality by Design and AI-driven analytics is creating opportunities across Vietnam’s pharmaceutical manufacturing ecosystem.
Vietnam’s medical simulation market is emerging as universities, hospitals and training institutions invest in safer, more effective clinical education. Estimated at US$20–30 million in 2025, it could reach US$45–65 million by 2030. Growing adoption of high-fidelity simulators, surgical training, VR, AR and AI-powered virtual patients is creating opportunities across medical education and healthcare training.
Vietnam’s bioinformatics market is expanding alongside growth in genomics, biotechnology, precision medicine and pharmaceutical research. Valued at US$76.75 million in 2022, the market could reach an estimated US$210–240 million by 2030. Increasing demand for genomic analysis, AI, multi-omics, drug discovery and cloud-based bioinformatics is creating opportunities across pharmaceuticals, biotechnology, diagnostics and research.
Vietnam’s Population Health Management market is expanding as healthcare providers and government bodies use data, analytics and connected platforms to improve outcomes across entire populations. Valued at US$374.6 million in 2025, the market is forecast to reach US$690.4 million by 2034. Growing adoption of electronic health records, AI-powered analytics, chronic disease management and remote monitoring is driving demand for integrated, data-driven health solutions.
Vietnam’s healthcare consulting market is expanding as hospitals, pharmaceutical companies, investors and technology providers navigate digital transformation, infrastructure development and regulatory change. Estimated at US$100–140 million in 2025, the market could reach US$175–230 million by 2030. Growing demand for strategy, digital transformation, market access, M&A, regulatory and AI advisory services is creating opportunities for specialist consulting firms.
Vietnam’s GLP-1 market is emerging as diabetes and obesity drive demand for innovative metabolic treatments. With growing access to therapies such as semaglutide and tirzepatide, alongside next-generation treatments, the market presents opportunities across pharmaceuticals, clinical research, distribution and digital health.
Vietnam’s connected medical device market is rapidly expanding as hospitals and healthcare providers adopt IoT, remote monitoring and AI-enabled technologies. Valued at approximately US$265 million in 2025, the market could approach US$750 million by 2031. Growth in smart monitoring, connected diagnostics, wearables and home-based care is creating opportunities across medical technology, digital health, AI, cloud infrastructure and cybersecurity.
Vietnam’s Hospital Information System market is rapidly expanding as hospitals accelerate digital transformation and adopt electronic medical records, cloud platforms and integrated health data systems. Valued at US$118.6 million in 2025 the market is forecast to reach US$247.5 million by 2034. Growing adoption of HIS, AI-powered analytics, interoperability and digital patient records is creating opportunities for health technology providers, system integrators and hospital technology suppliers.
Vietnam’s ultrasound market is expanding as hospitals, clinics and diagnostic centres invest in advanced, portable and AI-enabled imaging technologies. Valued at US$42.67 million in 2025, the market is projected to reach US$69.84 million by 2034, driven by healthcare modernisation and demand for earlier diagnosis. Portable ultrasound, POCUS and AI-assisted imaging are creating new opportunities across radiology, cardiology, obstetrics, emergency care and community healthcare.
Vietnam’s AI in healthcare market is entering a rapid growth phase, projected to expand from US$1.78 million in 2025 to US$22.48 million by 2034. Driven by digital transformation, AI adoption across diagnostics, medical imaging, clinical decision support, precision medicine and remote monitoring is creating new opportunities across hospitals, laboratories, pharmaceuticals, biotechnology and health technology.
Vietnam's emerging healthcare digital twins market offers long-term growth through AI, simulation, data integration and innovation.
Vietnam's remote patient monitoring market is expanding through connected healthcare, AI, wearables and chronic disease management.
Vietnam's medical aesthetics market is expanding rapidly, driven by rising incomes, advanced technologies, medical tourism, and consumer demand.
Vietnam's Healthcare IT market is accelerating through digital transformation, AI adoption, cloud computing, and healthcare modernisation initiatives.
Vietnam's revenue cycle management market is expanding through healthcare digitalisation, AI automation, integrated billing systems, and financial efficiency.
Vietnam's GLP-1 market is expanding through rising diabetes, obesity treatment, innovative therapies, and advancing metabolic healthcare.
Vietnam's orthopedic devices market is growing through ageing populations, advanced surgery, healthcare investment, and rising musculoskeletal care demand.
Vietnam's IoT medical devices market is expanding through connected care, remote monitoring, AI integration, and healthcare digitalisation.
Vietnam's life sciences sector is advancing through biotechnology, pharmaceutical innovation, research investment, and precision medicine technologies.
Vietnam's ventilator market is expanding, driven by respiratory disease, critical care investment, homecare adoption, and advancing intelligent ventilation technologies.
Vietnam's patient experience technology market is expanding through digital health, AI, telemedicine, and connected patient engagement platforms.
Vietnam's peritoneal dialysis market is growing through rising kidney disease, home-based care, digital monitoring, and nephrology investment.
Vietnam's AI clinical trials market is advancing through digital research, predictive analytics, faster recruitment, and pharmaceutical innovation.
Vietnam's sleep apnea devices market is expanding through home diagnostics, connected therapy, respiratory care, and digital health
Vietnam's endoscopy market is expanding through minimally invasive care, cancer screening, advanced imaging, and hospital modernisation
Vietnam's wearable healthcare market is expanding through digital health, chronic disease management, remote monitoring, and AI-enabled devices.
Vietnam's AI-powered remote patient monitoring market is growing through digital health, predictive analytics, and connected care
Vietnam's healthcare consulting market is rapidly expanding, driven by digital transformation, healthcare reform, investment, and innovation.
Vietnam's disposable endoscope market is growing through infection prevention, minimally invasive care, and healthcare modernisation initiatives
Vietnam's cardiovascular devices market is growing through rising heart disease, advanced technologies, and expanding specialist cardiac care
Vietnam's robotic surgery market is advancing through healthcare investment, minimally invasive innovation, and growing surgical technology adoption.
Vietnam's blood glucose monitoring market is growing through diabetes care, continuous monitoring, biosensors, and digital health.
Vietnam's hospital information systems market is expanding through digital transformation, electronic records, AI, and integrated healthcare platforms
Vietnam's rapidly growing GLP-1 market is transforming diabetes and obesity treatment through innovation, expanding healthcare access, and demand.
Vietnam's orthopaedic devices market is expanding through ageing demographics, advanced surgical innovation, healthcare investment, and rising demand.
Vietnam's digital health market is accelerating through AI, telemedicine, digital transformation, and expanding healthcare technology adoption.
Vietnam's radiotherapy market is expanding through oncology investment, precision treatment, advanced technologies, and growing cancer care.
Vietnam's next-generation sequencing market is expanding rapidly, advancing precision medicine, cancer diagnostics, genomics research and molecular testing through continued healthcare innovation.
Vietnam's healthcare AI market is accelerating through digital transformation, diagnostics innovation, government support, and healthcare modernisation.
Vietnam's Healthcare Information Exchange market is accelerating digital healthcare through interoperability, connected care, and secure health data exchange.
Vietnam's digital pathology market is expanding through AI, telepathology and precision medicine, transforming cancer diagnostics nationwide.
Vietnam's MRI market is growing through AI innovation, hospital expansion and increasing demand for advanced diagnostic imaging.
Vietnam's gene expression analysis market is expanding through genomics, precision medicine and advancing molecular diagnostics innovation.
Growing biotechnology investment is accelerating Vietnam's cell isolation market, supporting precision medicine and advanced biomedical research.
Vietnam's pharmaceutical inspection market is accelerating with automated quality control, AI adoption, and manufacturing investment.
Growing clinical research is driving Vietnam's adoption of eClinical technologies, digital trials, and advanced data management.
Vietnam's molecular infectious disease diagnostics market is expanding through surveillance investment, PCR adoption and laboratory modernisation.
Vietnam's healthcare cloud computing market is expanding rapidly, driving digital transformation, AI adoption, cybersecurity innovation and smarter connected healthcare systems.
Vietnam's clinical trial supplies market is expanding rapidly, driven by pharmaceutical investment, advanced logistics, cold-chain innovation and growing clinical research activity.
Vietnam's genomics market is growing rapidly, accelerating precision medicine through advanced sequencing, genetic testing, personalised healthcare and life sciences innovation.
Vietnam's remote patient monitoring market is expanding through digital health, AI, wearable technologies and connected care, improving chronic disease management and access.
Vietnam's GLP-1 market is growing rapidly, driven by rising diabetes, obesity, and demand for innovative therapies.
Vietnam's medical aesthetics market is projected to reach nearly US$150 million by 2030, becoming one of Southeast Asia's fastest-growing medical aesthetics markets.
Vietnam's transplant diagnostics market is estimated at US$10–12 million in 2025 and is projected to reach US$18–20 million by 2030.
Vietnam's surgical devices market is expanding through healthcare investment, minimally invasive surgery, advanced medical technologies and rising demand for modern surgical care.
